---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000989"
form_type: "8-K"
ticker: "GNLX"
cik: "0001231457"
company_name: "GENELUX Corp"
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:10:33.879390+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Genelux prices $20M public offering of 6.7M shares at $3.00

## Summary
- Priced underwritten public offering of 6,666,667 shares at $3.00 each.
- Gross proceeds of approx. $20M before underwriting discounts and expenses.
- Underwriter granted 30-day option to buy up to 1,000,000 additional shares.
- Proceeds for general corporate purposes including R&D, clinical trials, and working capital.
- Offering expected to close January 9, 2026; sole book-runner Lucid Capital Markets.

## SEC filing metadata
- accession: 0001493152-26-000989
- form_type: 8-K
- ticker: GNLX
- cik: 0001231457
- company_name: GENELUX Corp
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1231457/000149315226000989/0001493152-26-000989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1231457/000149315226000989/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000989
- JSON: https://secwatch.observer/filing/0001493152-26-000989.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000989.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.